SlideShare una empresa de Scribd logo
1 de 19
Descargar para leer sin conexión
Wessex AHSN and SPS
5th July 2017
Clare Howard FFRPS
FRPharmS Clinical Lead
Medicines Optimisation
Polypharmacy Prescribing Comparators
• In 2002, there were 617 million items dispensed, in 2012, there
were 1,000.5 million (an increase of 62%)
1
• In 2015, 1,083.6 million prescription items were dispensed
overall, a 1.8 per cent increase (19.1 million items) from 2014.
This is an increase of 50.4 per cent (363.4 million) on the
number dispensed in 2005; 720.3 million items
2
• The average number of prescription items per head of the
population in 2015 was 19.8, compared to 19.6 items in the
previous year and 14.3 in 2005 and 13 in 2003 2
• One third of over 75’s now take at least six medicines 3
IS IT HAPPENING IN ENGLAND?
POLYPHARMACY
So what?
• A person taking ten or more meds is 300% more likely
to be admitted to hospital (4)
• 6.5% of hospital admissions are for adverse effects of
medicines this rises to 17% in the over 65 age group.
• 30 – 50% of people do not take their medicine as
intended by the prescriber.
• Over 70% of hospital admissions for adverse reactions
to medicines could be avoided.
MEDICATION SAFETY
We aren’t getting it right…
Evidence from primary care shows:
• 1 in 20 prescription items has an error and 1 in 550 is serious
5
• Prescription errors had been made for one in eight patients
overall, and four in ten patients over 75 years of age. In all, 1 in
20 prescriptions written featured an error. Of the errors, 42%
were judged to be minor, 54% moderate and 4% severe.
• In 2013, there were over 1 billion items dispensed in England
therefore this equates to 1.8 million serious errors 3
• Adverse drug reactions account for 6.5% of hospital admissions
and over 70% of the ADRs are avoidable.
• Over 50% of errors were in 4 disease classes, antiplatelets,
NSAIDs, diuretics and anticoagulants5
POLYPHARMACY PRESCRIBING
COMPARATORS - THE STORY SO FAR….
Wessex AHSN workshop November 2015.
“Metrics” identified as a key starting point.
There seemed little point developing just for one
locality?
Why not engage NHS BSA and NHS Digital and
develop some national measures?
So we held a small workshop. GPs, Pharmacists,
BSA, RPS, NHS Digital and others. RCGP also aware
and engaged.
FOR EACH INDICATOR WE ASKED..
• Is it useful?
• Is it valid? (are there any health warnings)
• How would you use it?
• What other data sources might make it more
meaningful?
• In or out? i.e should it be included in the final
polypharmacy measures?
• Any other measures that the group could
suggest?
INITIAL SUGGESTIONS FOR POLYPHARMACY
PRESCRIBING INDICATORS
1. Average number of items per patient by CCG/ Practice
2. Average number of items per ASTRO PU by CCG/ Practice
3. Can you do average number of items in patients over 75?
4. Can you do average number of items in patient over 65
5. Number of patients on 10 or more meds over 65
6. Number of patients on 10 or more meds over 65
7. Number of patients on 4 or more meds over 65
8. Number of patients on 4 or more meds over 65
9. Number of patients on 20 or more meds over 65 and 75
10. Spend on top 10 drugs in STOPP part of STOPP start tool by
CCG in the over 75’s (controversial but this is a workshop)
11. Anticholinergic burden score in over 75s by CCG/ Practice
Have changed a bit since this first list…..
BSA AND HSCIC WORKED THEIR MAGIC….
LIMITATIONS:
• Historically, prescribing information was derived from the reimbursement
processes for dispensed medicines. However, the BSA is now able to
capture extra information that undoubtedly adds value to prescribing
measures.
• The NHS number can now be linked to prescription items. In this way, we
are able to demonstrate much better the quality of prescribing in key
areas.
• The polypharmacy prescribing comparators are the first suite of measures
to take advantage of this development. Currently, 92% of all prescription
items can be linked to an NHS number with an accuracy of 99%. Age and
date of birth can be linked to 73% of items with an accuracy of 99%. As the
utilisation of electronic prescribing (EPS) increases, the coverage and
accuracy of this data will increase.
• Therefore, CCGs are encouraged to drive up the uptake of EPS. To support
this improvement, EPS levels have been included at the start of these
comparators.
SO, THE FINAL DATA SET
These comparators will be available at GP Practice, and CCG level
and will include measure such as…
• The average number of unique medicines prescribed per patient
• Percentage of patients prescribed 8 or more unique medicines,
10 or more unique medicines, 15 or more unique medicines, 20
or more unique medicines
• Percentage of patients with an anticholinergic burden score of 6
or greater, 9 or greater, 12 or greater
• Percentage of patients prescribed multiple anticoagulant regimes
• Percentage of older patients prescribed medicines likely to cause
Acute Kidney Injury (DAMN Drugs)
• Percentage of patients prescribed a NSAID and one or more other
unique medicines likely to cause kidney injury (DAMN medicines)
PORTSMOUTH CCG PERCENTAGE OF
PATIENT WITH ACB SCORE OF 9 OR MORE
PORTSMOUTH CCG PERCENTAGE OF PATIENTS
ON 15 OR MORE UNIQUE MEDICINES
ePACT2 is now live and the roll out to users has begun.
Initially, only 2 users per CCG will be given access with further
users being added in a phased approach. Over the next few weeks
and months we will also be writing out to existing ePACT Users in
order to transfer them onto our new improved system. The plan is
to complete roll-out by Autumn 17.
If you would like to request access to ePACT 2 please drop the
NHS BSA an email nhsbsa.informationsystems@nhs.net
Further information regarding ePACT 2, including the benefits can
be found on NHS BSA’s
website (https://www.nhsbsa.nhs.uk/epact/epact2)
CORE PATIENT MESSAGES….
• Polypharmacy is not about reducing medicines costs – it is
about making sure you are only on the medicines you need,
to live well and avoid unnecessary or unplanned visits to
hospital.
• As you get older, medicines may no longer be appropriate for
you as your body changes. It may be time for a medication
review.
• Taking too many medicines increases your risk of going into
hospital.
• So – you should know your medicines. If not, speak to your
Pharmacist or GP.
• Don’t stop taking medicines without a review. Your local
Community Pharmacist can review how you use your
medicines and make recommendations to your GP. Ask them
today.
RESOURCES
http://www.sign.ac.uk/pdf/p
olypharmacy_guidance.pdf
See http://wessexahsn.org.uk/programmes/
11/medicines-optimisation
https://www.cppe.ac.uk
http://www.kingsfund.org.uk
Name Role/Organisation
Clare Howard Clinical Lead, Medicines Optimisation, Wessex Academic Health Science Network (Chair)
Graham Mitchell Information Services Manager, NHS Business Service Authority
Paul Brown Senior Pharmaceutical Adviser, NHS Digital
Neil Watson Clinical Director of Pharmacy and Medicines Management, Newcastle Hospitals NHS Foundation Trust
Vicki Rowse Programme Lead, Medicines Optimisation, Wessex Academic Health Science Network
Julia Blagburn Senior Lead Clinical Pharmacist for Older People's Medicine and Community Health, Newcastle Hospitals NHS Foundation
Trust.
Michelle Trevett Senior Pharmacist ,NHS Dorset Clinical Commissioning Group
Dr Paul Mason GP and Prescribing Lead ,NHS Dorset Clinical Commissioning Group
Dr Lawrence Brad GP and RCGP Polypharmacy Lead
Dr Simon Flack GP and Locality Lead ,NHS Dorset Clinical Commissioning Group
Simon Cooper Head of Prescribing Support, Portsmouth Clinical Commissioning Group
Katie Griffiths Medicines Safety Officer, Dorset University Healthcare NHS FT
Catherine Armstrong Lead Pharmacist – Pharmicus, English Pharmacy Board, Royal Pharmaceutical Society
Helen Kennedy Prescribing Analyst, NHS Dorset Clinical Commissioning Group
HUGE THANKS TO THE WORKING GROUP
WHERE NEXT???
EVALUATION: Does this
data truly identify those
most at risk from harm?
How do we join up with
secondary care??
Let’s not get to
10 medicines in
the first place! Research to
help us to stop
medicines
safely!
Trigger tool to
ensure a review
when patient is
about to go from
9-10 medicines
Tools that helps
the practice to
identify and
prioritise the
patients most in
need of review.
Health Warning:
‘indicators only indicate’

Más contenido relacionado

La actualidad más candente

Wellness presentation
Wellness presentationWellness presentation
Wellness presentation
Steve Dewitt
 
Chcpol501 a session five 250311
Chcpol501 a session five 250311Chcpol501 a session five 250311
Chcpol501 a session five 250311
lmabbott
 

La actualidad más candente (20)

Wellness presentation
Wellness presentationWellness presentation
Wellness presentation
 
Point of Care Testing in Pharmacies
Point of Care Testing in PharmaciesPoint of Care Testing in Pharmacies
Point of Care Testing in Pharmacies
 
1.5 Develop QI expertise - Sue Collis, Dr Farzana Hussain
1.5 Develop QI expertise - Sue Collis, Dr Farzana Hussain1.5 Develop QI expertise - Sue Collis, Dr Farzana Hussain
1.5 Develop QI expertise - Sue Collis, Dr Farzana Hussain
 
3.2 Hubs and collaboration - Greg Kalita, Dave Bearman
3.2 Hubs and collaboration - Greg Kalita, Dave Bearman3.2 Hubs and collaboration - Greg Kalita, Dave Bearman
3.2 Hubs and collaboration - Greg Kalita, Dave Bearman
 
Transforming the Patient Experience HISA EHealth NSW
Transforming the Patient Experience  HISA EHealth NSWTransforming the Patient Experience  HISA EHealth NSW
Transforming the Patient Experience HISA EHealth NSW
 
Evidence based medicine case study
Evidence based medicine case studyEvidence based medicine case study
Evidence based medicine case study
 
AI & The Patient Experience
AI & The Patient ExperienceAI & The Patient Experience
AI & The Patient Experience
 
Diabetes education case study
Diabetes education case studyDiabetes education case study
Diabetes education case study
 
Premise Health Overview
Premise Health OverviewPremise Health Overview
Premise Health Overview
 
Direct healthcare and premise health
Direct healthcare and premise healthDirect healthcare and premise health
Direct healthcare and premise health
 
Patient Activation: Where Do I Start?
Patient Activation: Where Do I Start?   Patient Activation: Where Do I Start?
Patient Activation: Where Do I Start?
 
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi MorganLeading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
 
Arvind madan innovativeapproachestoprovidingbetteraccesstoservices
Arvind madan innovativeapproachestoprovidingbetteraccesstoservicesArvind madan innovativeapproachestoprovidingbetteraccesstoservices
Arvind madan innovativeapproachestoprovidingbetteraccesstoservices
 
Chcpol501 a session five 250311
Chcpol501 a session five 250311Chcpol501 a session five 250311
Chcpol501 a session five 250311
 
Recommendations for Improving_Diagnosis
Recommendations for Improving_DiagnosisRecommendations for Improving_Diagnosis
Recommendations for Improving_Diagnosis
 
Things to Know About Patient Experience
Things to Know About Patient ExperienceThings to Know About Patient Experience
Things to Know About Patient Experience
 
The Nuka Model
The Nuka ModelThe Nuka Model
The Nuka Model
 
League Health Plan - Amwell Telehealth
League Health Plan - Amwell TelehealthLeague Health Plan - Amwell Telehealth
League Health Plan - Amwell Telehealth
 
Medtronic Trade Ad
Medtronic Trade AdMedtronic Trade Ad
Medtronic Trade Ad
 
Choices: MUS Spring Tour 2016. For Retirees
Choices: MUS Spring Tour 2016. For RetireesChoices: MUS Spring Tour 2016. For Retirees
Choices: MUS Spring Tour 2016. For Retirees
 

Destacado

Shared Decision Making - for pharmacists
Shared Decision Making - for pharmacistsShared Decision Making - for pharmacists
Shared Decision Making - for pharmacists
Hugo Leung
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
PM Society
 
Safe administration & preparation of cancer chemotherapy by irene weru
Safe administration & preparation of cancer chemotherapy by irene weruSafe administration & preparation of cancer chemotherapy by irene weru
Safe administration & preparation of cancer chemotherapy by irene weru
Kesho Conference
 
Smart phones and how they affect our lives
Smart phones and how they affect our livesSmart phones and how they affect our lives
Smart phones and how they affect our lives
ckap5
 
Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004
Patty Melody
 
Endogenous cannabinoid signaling
Endogenous cannabinoid signalingEndogenous cannabinoid signaling
Endogenous cannabinoid signaling
Adonis Sfera, MD
 
Medication errors powerpoint
Medication errors powerpointMedication errors powerpoint
Medication errors powerpoint
lexie_daryan
 

Destacado (20)

Shared Decision Making - for pharmacists
Shared Decision Making - for pharmacistsShared Decision Making - for pharmacists
Shared Decision Making - for pharmacists
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
 
Clinical Pharmacology in Orphan Drug Development
Clinical Pharmacology in Orphan Drug DevelopmentClinical Pharmacology in Orphan Drug Development
Clinical Pharmacology in Orphan Drug Development
 
Clinical decision support systems
Clinical decision support systemsClinical decision support systems
Clinical decision support systems
 
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
Palliative care: Pain Management for Patient with Diagnosis of Stomach Cancer...
 
Canabbis
CanabbisCanabbis
Canabbis
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
Everything you Need to Know About Progeria
Everything you Need to Know About ProgeriaEverything you Need to Know About Progeria
Everything you Need to Know About Progeria
 
Quality use of medicine
Quality use of medicineQuality use of medicine
Quality use of medicine
 
Equity, Health Quality and Shared Decision Making
Equity, Health Quality and Shared Decision MakingEquity, Health Quality and Shared Decision Making
Equity, Health Quality and Shared Decision Making
 
ECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
ECO 11: Medicines Optimisation Through Precision - Sir Munir PirmohamedECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
ECO 11: Medicines Optimisation Through Precision - Sir Munir Pirmohamed
 
Progeria Syndrome
Progeria SyndromeProgeria Syndrome
Progeria Syndrome
 
Safe administration & preparation of cancer chemotherapy by irene weru
Safe administration & preparation of cancer chemotherapy by irene weruSafe administration & preparation of cancer chemotherapy by irene weru
Safe administration & preparation of cancer chemotherapy by irene weru
 
Smart phones and how they affect our lives
Smart phones and how they affect our livesSmart phones and how they affect our lives
Smart phones and how they affect our lives
 
Robotics & Artificial Intelligence
Robotics &  Artificial  IntelligenceRobotics &  Artificial  Intelligence
Robotics & Artificial Intelligence
 
Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004Drug Use, Abuse And Misuse 2004
Drug Use, Abuse And Misuse 2004
 
On Cannabis
On CannabisOn Cannabis
On Cannabis
 
Endogenous cannabinoid signaling
Endogenous cannabinoid signalingEndogenous cannabinoid signaling
Endogenous cannabinoid signaling
 
Medication errors powerpoint
Medication errors powerpointMedication errors powerpoint
Medication errors powerpoint
 
Early Translational Research
Early Translational ResearchEarly Translational Research
Early Translational Research
 

Similar a Medicines Optimisation Polypharmacy Prescribing Comparators_Clare Howard

Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07
primary
 

Similar a Medicines Optimisation Polypharmacy Prescribing Comparators_Clare Howard (20)

Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
Polypharmacy - What next? (Planning for Wessex) Workshop - Clare Howard's pre...
 
2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson2o OTC & Cosmetics Conference, Raymond Anderson
2o OTC & Cosmetics Conference, Raymond Anderson
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
 
Dr John Duffy Polypharmacy and Frailty
Dr John Duffy   Polypharmacy and FrailtyDr John Duffy   Polypharmacy and Frailty
Dr John Duffy Polypharmacy and Frailty
 
Harm reduction on a large scale
Harm reduction on a large scaleHarm reduction on a large scale
Harm reduction on a large scale
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
 
Kelly Clark
Kelly ClarkKelly Clark
Kelly Clark
 
Partners’ Care Management Strategy: A 10-Year Journey
Partners’ Care Management Strategy: A 10-Year JourneyPartners’ Care Management Strategy: A 10-Year Journey
Partners’ Care Management Strategy: A 10-Year Journey
 
Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07Hbp Stategy Hypertension Management Initiative Feb07
Hbp Stategy Hypertension Management Initiative Feb07
 
Pediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationPediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events Presentation
 
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
 
1.5 - Clinical Pharmacists in General Practice - A necessity, not a luxury
1.5 - Clinical Pharmacists in General Practice - A necessity, not a luxury1.5 - Clinical Pharmacists in General Practice - A necessity, not a luxury
1.5 - Clinical Pharmacists in General Practice - A necessity, not a luxury
 
MedMAP finger prick blood test presentation from MaxiMedrx.com
MedMAP finger prick blood test presentation from MaxiMedrx.comMedMAP finger prick blood test presentation from MaxiMedrx.com
MedMAP finger prick blood test presentation from MaxiMedrx.com
 
See You Soon(er): Improving Access to NHS Care by Investing In Community Phar...
See You Soon(er): Improving Access to NHS Care by Investing In Community Phar...See You Soon(er): Improving Access to NHS Care by Investing In Community Phar...
See You Soon(er): Improving Access to NHS Care by Investing In Community Phar...
 
Integrating Pharmacists - JCU - Assoc Prof Sophie Couzos
Integrating Pharmacists - JCU - Assoc Prof Sophie CouzosIntegrating Pharmacists - JCU - Assoc Prof Sophie Couzos
Integrating Pharmacists - JCU - Assoc Prof Sophie Couzos
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
 
How Medication Adherence and Specialty Drugs Impact Employer Healthcare Costs
How Medication Adherence and Specialty Drugs Impact Employer Healthcare CostsHow Medication Adherence and Specialty Drugs Impact Employer Healthcare Costs
How Medication Adherence and Specialty Drugs Impact Employer Healthcare Costs
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
 
Managing ACO Populations across the Continuum Financially and Clinically - Do...
Managing ACO Populations across the Continuum Financially and Clinically - Do...Managing ACO Populations across the Continuum Financially and Clinically - Do...
Managing ACO Populations across the Continuum Financially and Clinically - Do...
 
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDayDr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
Dr. Greenberg CORD Mar 23-24, 2022 Rare Drug Strategy WebinarDay
 

Más de Health Innovation Wessex

Más de Health Innovation Wessex (20)

Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)Reducing opioid prescribing (in general practice)
Reducing opioid prescribing (in general practice)
 
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...
 
The SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway ToolThe SBAR Patient Engagement Pathway Tool
The SBAR Patient Engagement Pathway Tool
 
Reducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailtyReducing medication related falls risk in patients with severe frailty
Reducing medication related falls risk in patients with severe frailty
 
Assessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviewsAssessing the outcomes of structured medication reviews
Assessing the outcomes of structured medication reviews
 
Polypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinicsPolypharmacy SMR reviews in outpatient bone health clinics
Polypharmacy SMR reviews in outpatient bone health clinics
 
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...
 
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...
 
Genomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in EnglandGenomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in England
 
Pharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approachPharmacogenomics into practice - stroke services and a systems approach
Pharmacogenomics into practice - stroke services and a systems approach
 
Pharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley WickensPharmacogenomics in Practice - Dr Hayley Wickens
Pharmacogenomics in Practice - Dr Hayley Wickens
 
Working with patients to support transformational healthcare
Working with patients to support transformational healthcareWorking with patients to support transformational healthcare
Working with patients to support transformational healthcare
 
The Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-LaceyThe Generation study by Alice Tuff-Lacey
The Generation study by Alice Tuff-Lacey
 
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...
 
Review of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdfReview of patients on high dose opioids at Living Well PCN.pdf
Review of patients on high dose opioids at Living Well PCN.pdf
 
Re-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdfRe-establishing autonomy in elderly frail patients.pdf
Re-establishing autonomy in elderly frail patients.pdf
 
Improving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdfImproving Medication Reviews using the NO TEARS Tool.pdf
Improving Medication Reviews using the NO TEARS Tool.pdf
 
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfImproving care in County Durham under the STOMP agenda - A 5 year review.pdf
Improving care in County Durham under the STOMP agenda - A 5 year review.pdf
 
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Impact of an EMIS search to prioritise care home residents for a pharmacist l...
Impact of an EMIS search to prioritise care home residents for a pharmacist l...
 
Identifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdfIdentifying Orthostatic Hypotension caused by Medication.pdf
Identifying Orthostatic Hypotension caused by Medication.pdf
 

Último

raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetraisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Sheetaleventcompany
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
Sheetaleventcompany
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Punjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
Punjab Call Girls Contact Number +919053,900,678 Punjab Call GirlsPunjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
Punjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
@Chandigarh #call #Girls 9053900678 @Call #Girls in @Punjab 9053900678
 
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
mahaiklolahd
 
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetsurat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Chandigarh
 
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetPatna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Deny Daniel
 
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 

Último (20)

raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetraisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
raisen Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Sexy Call Girl Dharmapuri Arshi 💚9058824046💚 Dharmapuri Escort Service
Sexy Call Girl Dharmapuri Arshi 💚9058824046💚 Dharmapuri Escort ServiceSexy Call Girl Dharmapuri Arshi 💚9058824046💚 Dharmapuri Escort Service
Sexy Call Girl Dharmapuri Arshi 💚9058824046💚 Dharmapuri Escort Service
 
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
Premium Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangalor...
 
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
(Deeksha) 💓 9920725232 💓High Profile Call Girls Navi Mumbai You Can Get The S...
 
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
💚 Punjabi Call Girls In Chandigarh 💯Lucky 🔝8868886958🔝Call Girl In Chandigarh
 
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real MeetVip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
Vip Call Girls Makarba 👙 6367187148 👙 Genuine WhatsApp Number for Real Meet
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Punjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
Punjab Call Girls Contact Number +919053,900,678 Punjab Call GirlsPunjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
Punjab Call Girls Contact Number +919053,900,678 Punjab Call Girls
 
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sangli Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
Call Girl in Bangalore 9632137771 {LowPrice} ❤️ (Navya) Bangalore Call Girls ...
 
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance PaymentsEscorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
Escorts Service Ahmedabad🌹6367187148 🌹 No Need For Advance Payments
 
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali PunjabGorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
Gorgeous Call Girls Mohali {7435815124} ❤️VVIP ANGEL Call Girls in Mohali Punjab
 
Call Girls Service Mohali {7435815124} ❤️VVIP PALAK Call Girl in Mohali Punjab
Call Girls Service Mohali {7435815124} ❤️VVIP PALAK Call Girl in Mohali PunjabCall Girls Service Mohali {7435815124} ❤️VVIP PALAK Call Girl in Mohali Punjab
Call Girls Service Mohali {7435815124} ❤️VVIP PALAK Call Girl in Mohali Punjab
 
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetsurat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
surat Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetPatna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Patna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
 
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kozhikode Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 

Medicines Optimisation Polypharmacy Prescribing Comparators_Clare Howard

  • 1. Wessex AHSN and SPS 5th July 2017 Clare Howard FFRPS FRPharmS Clinical Lead Medicines Optimisation Polypharmacy Prescribing Comparators
  • 2. • In 2002, there were 617 million items dispensed, in 2012, there were 1,000.5 million (an increase of 62%) 1 • In 2015, 1,083.6 million prescription items were dispensed overall, a 1.8 per cent increase (19.1 million items) from 2014. This is an increase of 50.4 per cent (363.4 million) on the number dispensed in 2005; 720.3 million items 2 • The average number of prescription items per head of the population in 2015 was 19.8, compared to 19.6 items in the previous year and 14.3 in 2005 and 13 in 2003 2 • One third of over 75’s now take at least six medicines 3 IS IT HAPPENING IN ENGLAND?
  • 3. POLYPHARMACY So what? • A person taking ten or more meds is 300% more likely to be admitted to hospital (4) • 6.5% of hospital admissions are for adverse effects of medicines this rises to 17% in the over 65 age group. • 30 – 50% of people do not take their medicine as intended by the prescriber. • Over 70% of hospital admissions for adverse reactions to medicines could be avoided.
  • 4. MEDICATION SAFETY We aren’t getting it right… Evidence from primary care shows: • 1 in 20 prescription items has an error and 1 in 550 is serious 5 • Prescription errors had been made for one in eight patients overall, and four in ten patients over 75 years of age. In all, 1 in 20 prescriptions written featured an error. Of the errors, 42% were judged to be minor, 54% moderate and 4% severe. • In 2013, there were over 1 billion items dispensed in England therefore this equates to 1.8 million serious errors 3 • Adverse drug reactions account for 6.5% of hospital admissions and over 70% of the ADRs are avoidable. • Over 50% of errors were in 4 disease classes, antiplatelets, NSAIDs, diuretics and anticoagulants5
  • 5. POLYPHARMACY PRESCRIBING COMPARATORS - THE STORY SO FAR…. Wessex AHSN workshop November 2015. “Metrics” identified as a key starting point. There seemed little point developing just for one locality? Why not engage NHS BSA and NHS Digital and develop some national measures? So we held a small workshop. GPs, Pharmacists, BSA, RPS, NHS Digital and others. RCGP also aware and engaged.
  • 6. FOR EACH INDICATOR WE ASKED.. • Is it useful? • Is it valid? (are there any health warnings) • How would you use it? • What other data sources might make it more meaningful? • In or out? i.e should it be included in the final polypharmacy measures? • Any other measures that the group could suggest?
  • 7. INITIAL SUGGESTIONS FOR POLYPHARMACY PRESCRIBING INDICATORS 1. Average number of items per patient by CCG/ Practice 2. Average number of items per ASTRO PU by CCG/ Practice 3. Can you do average number of items in patients over 75? 4. Can you do average number of items in patient over 65 5. Number of patients on 10 or more meds over 65 6. Number of patients on 10 or more meds over 65 7. Number of patients on 4 or more meds over 65 8. Number of patients on 4 or more meds over 65 9. Number of patients on 20 or more meds over 65 and 75 10. Spend on top 10 drugs in STOPP part of STOPP start tool by CCG in the over 75’s (controversial but this is a workshop) 11. Anticholinergic burden score in over 75s by CCG/ Practice Have changed a bit since this first list…..
  • 8. BSA AND HSCIC WORKED THEIR MAGIC….
  • 9. LIMITATIONS: • Historically, prescribing information was derived from the reimbursement processes for dispensed medicines. However, the BSA is now able to capture extra information that undoubtedly adds value to prescribing measures. • The NHS number can now be linked to prescription items. In this way, we are able to demonstrate much better the quality of prescribing in key areas. • The polypharmacy prescribing comparators are the first suite of measures to take advantage of this development. Currently, 92% of all prescription items can be linked to an NHS number with an accuracy of 99%. Age and date of birth can be linked to 73% of items with an accuracy of 99%. As the utilisation of electronic prescribing (EPS) increases, the coverage and accuracy of this data will increase. • Therefore, CCGs are encouraged to drive up the uptake of EPS. To support this improvement, EPS levels have been included at the start of these comparators.
  • 10. SO, THE FINAL DATA SET These comparators will be available at GP Practice, and CCG level and will include measure such as… • The average number of unique medicines prescribed per patient • Percentage of patients prescribed 8 or more unique medicines, 10 or more unique medicines, 15 or more unique medicines, 20 or more unique medicines • Percentage of patients with an anticholinergic burden score of 6 or greater, 9 or greater, 12 or greater • Percentage of patients prescribed multiple anticoagulant regimes • Percentage of older patients prescribed medicines likely to cause Acute Kidney Injury (DAMN Drugs) • Percentage of patients prescribed a NSAID and one or more other unique medicines likely to cause kidney injury (DAMN medicines)
  • 11. PORTSMOUTH CCG PERCENTAGE OF PATIENT WITH ACB SCORE OF 9 OR MORE
  • 12. PORTSMOUTH CCG PERCENTAGE OF PATIENTS ON 15 OR MORE UNIQUE MEDICINES
  • 13. ePACT2 is now live and the roll out to users has begun. Initially, only 2 users per CCG will be given access with further users being added in a phased approach. Over the next few weeks and months we will also be writing out to existing ePACT Users in order to transfer them onto our new improved system. The plan is to complete roll-out by Autumn 17. If you would like to request access to ePACT 2 please drop the NHS BSA an email nhsbsa.informationsystems@nhs.net Further information regarding ePACT 2, including the benefits can be found on NHS BSA’s website (https://www.nhsbsa.nhs.uk/epact/epact2)
  • 14. CORE PATIENT MESSAGES…. • Polypharmacy is not about reducing medicines costs – it is about making sure you are only on the medicines you need, to live well and avoid unnecessary or unplanned visits to hospital. • As you get older, medicines may no longer be appropriate for you as your body changes. It may be time for a medication review. • Taking too many medicines increases your risk of going into hospital. • So – you should know your medicines. If not, speak to your Pharmacist or GP. • Don’t stop taking medicines without a review. Your local Community Pharmacist can review how you use your medicines and make recommendations to your GP. Ask them today.
  • 16. Name Role/Organisation Clare Howard Clinical Lead, Medicines Optimisation, Wessex Academic Health Science Network (Chair) Graham Mitchell Information Services Manager, NHS Business Service Authority Paul Brown Senior Pharmaceutical Adviser, NHS Digital Neil Watson Clinical Director of Pharmacy and Medicines Management, Newcastle Hospitals NHS Foundation Trust Vicki Rowse Programme Lead, Medicines Optimisation, Wessex Academic Health Science Network Julia Blagburn Senior Lead Clinical Pharmacist for Older People's Medicine and Community Health, Newcastle Hospitals NHS Foundation Trust. Michelle Trevett Senior Pharmacist ,NHS Dorset Clinical Commissioning Group Dr Paul Mason GP and Prescribing Lead ,NHS Dorset Clinical Commissioning Group Dr Lawrence Brad GP and RCGP Polypharmacy Lead Dr Simon Flack GP and Locality Lead ,NHS Dorset Clinical Commissioning Group Simon Cooper Head of Prescribing Support, Portsmouth Clinical Commissioning Group Katie Griffiths Medicines Safety Officer, Dorset University Healthcare NHS FT Catherine Armstrong Lead Pharmacist – Pharmicus, English Pharmacy Board, Royal Pharmaceutical Society Helen Kennedy Prescribing Analyst, NHS Dorset Clinical Commissioning Group HUGE THANKS TO THE WORKING GROUP
  • 17.
  • 18. WHERE NEXT??? EVALUATION: Does this data truly identify those most at risk from harm? How do we join up with secondary care?? Let’s not get to 10 medicines in the first place! Research to help us to stop medicines safely! Trigger tool to ensure a review when patient is about to go from 9-10 medicines Tools that helps the practice to identify and prioritise the patients most in need of review.